Inari Medical Inc Stock
Inari Medical Inc Stock price
Key metrics
| Market capitalization | $2.65b |
| Enterprise Value | $2.58b |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | 129.56 |
| EV/Sales (TTM) EV/Sales | 4.70 |
| P/S ratio (TTM) P/S ratio | 4.84 |
| P/B ratio (TTM) P/B ratio | 6.25 |
| Revenue growth (TTM) Revenue growth | 24.67% |
| Revenue (TTM) Revenue | $547.47m |
Is Inari Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
Inari Medical Inc Stock Analysis
Analyst Opinions
15 Analysts have issued a Inari Medical Inc forecast:
Analyst Opinions
15 Analysts have issued a Inari Medical Inc forecast:
Financial data from Inari Medical Inc
| Jun '24 |
+/-
%
|
||
| Revenue | 547 547 |
25%
25%
|
|
| Gross Profit | 468 468 |
22%
22%
|
|
| EBITDA | -9.58 -9.58 |
31%
31%
|
EBIT (Operating Income) EBIT | -23 -23 |
3%
3%
|
| Net Profit | -57 -57 |
255%
255%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Inari Medical Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Inari Medical Inc Stock News
Company Profile
Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It produces ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.
| Head office | United States |
| CEO | Andrew Hykes |
| Employees | 1,300 |
| Founded | 2011 |
| Website | www.inarimedical.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
